: Dr. William (Bill) S. Dalton is the Founder of M2Gen (now known as AsterInsights), a national biotechnology subsidiary of the Moffitt Cancer Center. He is the past President (2002-2012), CEO & Center Director of Moffitt Cancer Center, an NCI-Designated Comprehensive Cancer Center. Before joining Moffitt as Center Director in 2002, Dr. Dalton was the Dean of the University of Arizona College of Medicine. His research interests include the development of information systems that enable the aggregation, organization, and sharing of patient data in real-time to enhance the discovery and delivery of evidence-based precision medicine. Past funding was supported by 34 grants with 16 being NCI/NIH funded. While at Moffitt, he led the development of the “Total Cancer Care Protocol,” a prospective study designed to follow patients throughout their lifetime, with patients consenting to donate their clinical data, tissue, and molecular data to support precision medicine. In 2014, the Moffitt Cancer Center partnered with the James Cancer Center at Ohio State University to form ORIEN, a cancer center alliance of eighteen cancer centers dedicated to data sharing and collaborative research. The number of patients who have consented to the Total Cancer Care Protocol is now over 325,000. Dr. Dalton’s basic and translational research interests focus on molecular mechanisms of drug resistance and drug discovery. He has authored over 200 publications, served on several editorial boards, and has twelve patents in the fields of drug discovery and computer/information networking. He has served on numerous not-for-profit boards and is the past-Chair of the Personalized Medicine Coalition (personalizedmedicine.org), and past-President of the Association of American Cancer Institutes (aaci-cancer.org). Dr. Dalton is the past Chair of the Pharmaceutical Sciences Section of the American Association for the Advancement of Science (aaas.org) and is the current Board Chair of the Institute of Human and Machine Cognition (ihmc.us). He was also the Chair of the American Association of Cancer Research (aacr.org)Trust in Science Task Force.